#SenjuPharma has launched a new drug for #dryeyedisease (DED) in #Japan, #Avarept, which is the first drug in the #TRPV1antagonist class to reach the market.
Table showing prevalence of dry eye disease across 10 autoimmune diseases by sex in Taiwan. Lists total cases and dry eye disease numbers with percentages for total, male, and female for each disease.
Among patients with #AutoimmuneDisease in Taiwan, #DryEyeDisease prevalence was highest in Sjögren syndrome (81.3%) and typically preceded autoimmune diagnosis by 3 years, highlighting early ocular involvement.
ja.ma/4saS53u
✨ Nanoemulsion vs Conventional Cyclosporine in #DryEyeDisease
💧 ↑ Tear production (Schirmer) at 12 wks with nanoemulsion
⏱️ ↑ TBUT
📝 Similar OSDI symptom relief
⚖️ Comparable safety
📊 Systematic review & meta-analysis guiding evidence-based DED care
#Ophthalmology
www.sciencedirect.com/science/arti...
Combined MSC and Tβ4 therapy ameliorates #DryEyeDisease by inhibiting GLS1 to restore glutamine levels, and suppresses the IκBα/NF-κB signaling to protect corneal epithelial cells from #OxidativeStress-induced #Apoptosis.
#OpenAccess: doi.org/10.1038/s413...
Marjan Farid, MD, discusses the challenges of dry eye disease and what physicians and staff can do to address this.
Read the full article at our website: www.ophthalmicprofessional.com/issues/2025/....
#dryeye #dryeyedisease #dryeyetesting #DED #ophthalmology
Damon Dierker, OD, FAAO, discusses efficiency in dry eye testing and how Eye Surgeons of Indiana identifies patients who may need treatment without significantly disrupting clinic flow. www.ophthalmicprofessional.com/issues/2025/... #dryeye
#dryeyedisease #dryeyetesting #DED #ophthalmology
Test your knowledge of #DryEyeDisease with this #CME #COPE activity >>
www.healio.com/cme/osdcme/d...
#ophthalmology #optometry
Complete this #CE activity to stay up to date on neurostimulatory agents for #DryEyeDisease.
Claim your credits now >> www.healio.com/cme/osdcme/d... #ophthalmology #optometry
#AAO2025: A novel topical agent may offer rapid and sustained relief for patients with #DryEyeDisease, according to research presented at the American Academy of Ophthalmology 2025 annual meeting held in Orlando, FL, October 18 to 20.
Read more: https://bit.ly/3WiIv0B
#Ophthalmology #MedSky
Modulating #Glutamine metabolism via MSC + Tβ4 therapy alleviates #DryEyeDisease by suppressing #CornealEpithelialCell subclusters and IκBα/NF-κB signaling, with #GLS1 regulation crucial for maximizing therapeutic efficacy. #medsky
#OpenAccess in #STTT: doi.org/10.1038/s413...
Do you know the answer to this question about #DryEyeDisease?
Test your knowledge with this #CME #COPE activity >> www.healio.com/cme/osdcme/d...
#ophthalmology #optometry
#AAO2025: A novel #microRNA eye drop therapeutic option to manage either #DryEyeDisease (DED) or #CornealRepair, or both, may be on the horizon as demonstrated by 2 #ClinicalTrial results.
Read more: https://bit.ly/47m7WmQ
#Ophthalmology #MedSky #EyeSky
Read Jane Shuman's October Viewpoint From the Editor column here: www.ophthalmicprofessional.com/issues/2025/....
#dryeyedisease #dryeyetesting #DED #ocularsurfacedisease #OSD #priorauthorization #AAOP #presbyopia #ophthalmictechnician #ophthalmicprofessional #ophthalmicstaff #ophthalmology
The October issue of OP highlights See Vision Eye Institute in Palm Beach County, Florida, looks at managing ocular surface disease, efficiency in dry eye testing, features a spotlight on the AAOP’s Amy Jost+more! www.ophthalmicprofessional.com/issues/2025/... #dryeye #dryeyedisease
A novel #DryEyeDisease (DED) therapy combining MSCs & Tβ4 boosts #glutamine metabolism to reduce inflammation & apoptosis, with GLS1 targeting enhancing efficacy, highlighting a new anti-inflammatory strategy. #bluesky
#STTT #OpenAccess: www.nature.com/articles/s41...
Complete this #CE activity to stay up-to-date on the latest data on neurostimulation agents for #DryEyeDisease management.
Claim your credits now >> www.healio.com/cme/osdcme/d...
would lock me out for awhile with a pin I don't know. Advice, please?! #DryEyeDisease #MeibomianGlandDysfunction #spoomie #medsky #disabiloty
Stuart Therapeutics’ dry eye drug ST-100 failed its Phase 3 trial. Despite promising Phase 2 data, the novel collagen-repair eyedrop didn’t meet endpoints. They plan another study—but it’s a tough road in #DryEyeDisease R&D. #Biotech #Ophthalmology
I am delighted to share that the double cauterization of my left eye tear ducts was a success. I'm now able to wear my glasses and blue light blocker wearovers inside of my home instead of my non prescription blue light blocking shades!
I share because I want to raise awareness
#dryeyedisease #DED
The next few weeks are going to be brutal. 😩 😫
#grasspollen
#pollen #dryeyedisease 🥺
#dryeyediseaseawareness #DED
My eye allergies are 1,000% worse. I'm hiding inside.
scene: Scarface 😂
#rainfall #downpour #flooding #grasspollen #allergies #sanantonio #texas
I couldn't resist. Today, my eye allergies are 1,000%. I'm hiding inside. 😂 scene: Scarface
#rainfall #downpour #rain #grasspollen #flooding #allergies ##dryeyediseaseawareness #dryeyedisease #DED #Scarface #alpacino
In this month's Industry Insider, Harrow’s chief scientific officer Amir H. Shojaei, PharmD, PhD, provides an update on Vevye+discusses the Vevye Access for All initiative, Harrow’s partnership with Cencora+more. ophthalmologymanagement.com/issues/2025/... #dryeye #dryeyedisease #ophthalmology
Desperate times call for desperate measures. It's not comfortable in the long term. But it works, you know, for a quick post or response. 🤷🏾♀️ #dryeyediseaseawareness #dryeyedisease #DED
Song:Eyes on Fire by Blue Foundation
Desperate times call for desperate measures. It's not comfortable in the long term. But it works, you know, for a quick post or response. 🤷🏾♀️ #dryeyediseaseawareness #dryeyedisease #DED
Desperate times call for desperate measures. It's not comfortable in the long term. But it works, you know, for a quick post or response. 🤷🏾♀️ #dryeyediseaseawareness #dryeyedisease #DED
Person using a laptop with a promotional banner for ARVO Special Interest Group virtual sessions on June 10, 12, 24, and 26, free for ARVO members. Visit ARVO.org/SIGS for more details.
Do not miss @arvoinfo.bsky.social's Special Interest Group (SIG) sessions tomorrow! Check out the lineup of engaging discussions you can join online, such as Controversies in #DryEyeDisease and Setting up a lab as a new PI. Free for ARVO members. Sign up now. bit.ly/3NcRlZC
@arvoinfo.bsky.social Special Interest Group (SIG) sessions start next week online! Check out the engaging discussions lined up for June 10 & 12, such as Controversies in #DryEyeDisease and #CharlesBonnetSyndrome: New hallucinations. Free for ARVO members. Sign up now www.arvo.org/education/sp...
Person using a laptop with a promotional banner for ARVO Special Interest Group virtual sessions on June 10, 12, 24, and 26, free for ARVO members. Visit ARVO.org/SIGS for more details.
@arvoinfo.bsky.social Special Interest Group (SIG) sessions start next week online! Check out the engaging discussions lined up for June 10 & 12, such as Controversies in #DryEyeDisease and #CharlesBonnetSyndrome: New hallucinations. Free for ARVO members. Sign up now bit.ly/3NcRlZC
Prompting patients with questions like, “How often do you experience dry eye symptoms, and when do they seem to be the worst for you?” can provide insights into how DED is affecting their daily life, says Marjan Farid, MD. ophthalmologymanagement.com/issues/2025/... #dryeyedisease #ophthalmology
Alcon has announced FDA approval of Tryptyr (acoltremon ophthalmic solution) 0.003%, formerly known as AR-15512, for the treatment of signs and symptoms of dry eye disease. www.ophthalmicprofessional.com/issues/2025/... #Alcon #dryeye #dryeyedisease #DED #ophthalmology #eyecare
Alcon has announced FDA approval of Tryptyr (acoltremon ophthalmic solution) 0.003%, formerly known as AR-15512, for the treatment of signs and symptoms of dry eye disease. Learn more here: ow.ly/MfuH50W11ZJ.
#dryeye #dryeyedisease #DED #ophthalmologist #ophthalmology #youngophthalmologists #eyecare